THB Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

THB Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-635,450	Closed	-$5.29M	–	262
2014 Q3	$5.29M	Buy	635,450 +16,340	+3%	+$151K	0.37%	118
2014 Q2	$7.16M	Sell	619,110 -10,880	-2%	-$112K	0.45%	103
2014 Q1	$7.99M	Buy	629,990 +155,480	+33%	+$2.01M	0.48%	89
2013 Q4	$5.13M	Buy	474,510 +43,700	+10%	+$508K	0.28%	145
2013 Q3	$5.33M	Sell	430,810 -8,350	-2%	-$115K	0.33%	129
2013 Q2	$5.86M	Buy	+439,160	New	+$5.65M	0.39%	112

Other funds holding DSCI

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return